Sisse H Njor1, My von Euler-Chelpin1, Anne Tjønneland2, Ilse Vejborg3, Elsebeth Lynge4. 1. Department of Public Health, University of Copenhagen, Denmark. 2. Danish Cancer Society, Copenhagen, Denmark. 3. Center of Diagnostic Imaging, Copenhagen University Hospital, Denmark. 4. Department of Public Health, University of Copenhagen, Denmark. Electronic address: elsebeth@sund.ku.dk.
Abstract
AIM: Obese women tend to participate less in breast cancer screening than normal weight women. However, obese women have fattier breast than normal weight women, and screening mammography works better in fatty than in dense breasts. One might, therefore, hypothesise that obese women would actually benefit more from screening than other women. METHODS: We combined data from the Danish Diet, Cancer and Health study and the organised population-based screening mammography programme in Copenhagen, Denmark. Women were categorised according to body mass index (BMI) (<20; 20 to <25; 25 to <30; 30 to <35, and 35+). We measured recall rate, sensitivity and specificity for subsequent screens with a 2-year follow-up period. RESULTS: The study included 6787 women. The recall rate varied from 1.4% for women with BMI <20 to 1.9% for women with BMI 35+, test for trend p = 0.86. Sensitivity varied from 42% (95% confidence interval [CI] 20-64%) for women with BMI <20 to 100% (95% CI 69-100%) for women with BMI 35+, test for trend p = 0.015. Specificity was fairly constant across BMI levels, being on average 98.8%, test for trend p = 0.79. CONCLUSION: This study showed that obese women were the ones with the highest sensitivity of screening mammography, while the specificity of screening remained stable across weight groups. Screening programmes should be organized to encourage these women to overcome obstacles for participation.
AIM: Obesewomen tend to participate less in breast cancer screening than normal weight women. However, obesewomen have fattier breast than normal weight women, and screening mammography works better in fatty than in dense breasts. One might, therefore, hypothesise that obesewomen would actually benefit more from screening than other women. METHODS: We combined data from the Danish Diet, Cancer and Health study and the organised population-based screening mammography programme in Copenhagen, Denmark. Women were categorised according to body mass index (BMI) (<20; 20 to <25; 25 to <30; 30 to <35, and 35+). We measured recall rate, sensitivity and specificity for subsequent screens with a 2-year follow-up period. RESULTS: The study included 6787 women. The recall rate varied from 1.4% for women with BMI <20 to 1.9% for women with BMI 35+, test for trend p = 0.86. Sensitivity varied from 42% (95% confidence interval [CI] 20-64%) for women with BMI <20 to 100% (95% CI 69-100%) for women with BMI 35+, test for trend p = 0.015. Specificity was fairly constant across BMI levels, being on average 98.8%, test for trend p = 0.79. CONCLUSION: This study showed that obesewomen were the ones with the highest sensitivity of screening mammography, while the specificity of screening remained stable across weight groups. Screening programmes should be organized to encourage these women to overcome obstacles for participation.
Authors: Annie Tang; Caitlin M Cohan; Keith S Hansen; Genna Beattie; Heather I Greenwood; Rita A Mukhtar Journal: Breast Cancer Res Treat Date: 2021-03-27 Impact factor: 4.872
Authors: Samuel G Smith; Ivana Sestak; Michelle A Morris; Michelle Harvie; Anthony Howell; John Forbes; Jack Cuzick Journal: Breast Cancer Res Treat Date: 2021-03-03 Impact factor: 4.872
Authors: Braden Miller; Hunter Chalfant; Alexandra Thomas; Elizabeth Wellberg; Christina Henson; Molly W McNally; William E Grizzle; Ajay Jain; Lacey R McNally Journal: Int J Mol Sci Date: 2021-03-09 Impact factor: 5.923